logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Gregory, Matthew Alan
    Ceo & Cso born in July 1975
    Individual (4 offsprings)
    Officer
    icon of calendar 2012-12-18 ~ now
    OF - Director → CIF 0
  • 2
    Booth, Robert Alec
    Non-Executive Director born in June 1952
    Individual (9 offsprings)
    Officer
    icon of calendar 2013-03-21 ~ now
    OF - Director → CIF 0
  • 3
    Wilkinson, Barrie, Professor
    Non-Executive Director born in July 1969
    Individual (2 offsprings)
    Officer
    icon of calendar 2012-12-18 ~ now
    OF - Director → CIF 0
  • 4
    Moss, Steven James, Dr
    Cto born in April 1974
    Individual (4 offsprings)
    Officer
    icon of calendar 2012-12-18 ~ now
    OF - Director → CIF 0
Ceased 3
  • 1
    Matthew Alan Gregory
    Born in July 1975
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2025-03-05
    PE - Has significant influence or control → CIF 0
  • 2
    Dr Steven James Moss
    Born in April 1974
    Individual (4 offsprings)
    Person with significant control
    icon of calendar 2016-04-06 ~ 2025-03-05
    PE - Has significant influence or control → CIF 0
  • 3
    Aspland, Simon Eric, Dr
    Ceo born in November 1970
    Individual (2 offsprings)
    Officer
    icon of calendar 2023-11-02 ~ 2024-04-22
    OF - Director → CIF 0
parent relation
Company in focus

ISOMERASE THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
372024-01-01 ~ 2024-12-31
372023-01-01 ~ 2023-12-31
Intangible Assets
5,125 GBP2024-12-31
6,672 GBP2023-12-31
Property, Plant & Equipment
501,711 GBP2024-12-31
586,442 GBP2023-12-31
Total Inventories
13,835 GBP2024-12-31
Debtors
1,485,063 GBP2024-12-31
978,726 GBP2023-12-31
Cash at bank and in hand
1,393,735 GBP2024-12-31
1,743,328 GBP2023-12-31
Current Assets
2,892,633 GBP2024-12-31
2,722,054 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-484,583 GBP2024-12-31
-486,901 GBP2023-12-31
Net Current Assets/Liabilities
2,408,050 GBP2024-12-31
2,235,153 GBP2023-12-31
Total Assets Less Current Liabilities
2,914,886 GBP2024-12-31
2,828,267 GBP2023-12-31
Net Assets/Liabilities
2,914,886 GBP2024-12-31
2,828,267 GBP2023-12-31
Equity
Called up share capital
8,985 GBP2024-12-31
8,880 GBP2023-12-31
Share premium
192,257 GBP2024-12-31
185,263 GBP2023-12-31
Retained earnings (accumulated losses)
2,713,644 GBP2024-12-31
2,634,124 GBP2023-12-31
Equity
2,914,886 GBP2024-12-31
2,828,267 GBP2023-12-31
Property, Plant & Equipment - Depreciation rate used
Plant and equipment
202024-01-01 ~ 2024-12-31
Office equipment
332024-01-01 ~ 2024-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
7,736 GBP2024-12-31
7,736 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
2,611 GBP2024-12-31
1,064 GBP2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
5,125 GBP2024-12-31
6,672 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,282,675 GBP2024-12-31
1,186,780 GBP2023-12-31
Computers
95,741 GBP2024-12-31
84,982 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
1,422,039 GBP2024-12-31
1,304,440 GBP2023-12-31
Property, Plant & Equipment - Other Disposals
Plant and equipment
-375 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals
-375 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
640,509 GBP2023-12-31
Computers
70,462 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
717,998 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Owned/Freehold
202,705 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
Plant and equipment
-375 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-375 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
824,625 GBP2024-12-31
Computers
80,265 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
920,328 GBP2024-12-31
Property, Plant & Equipment
Plant and equipment
458,050 GBP2024-12-31
546,271 GBP2023-12-31
Computers
15,476 GBP2024-12-31
14,520 GBP2023-12-31
Other Debtors
Non-current
21,782 GBP2024-12-31
21,782 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
1,091,374 GBP2024-12-31
426,906 GBP2023-12-31
Other Debtors
Current
188,545 GBP2024-12-31
292,440 GBP2023-12-31
Prepayments/Accrued Income
Current
183,362 GBP2024-12-31
237,598 GBP2023-12-31
Debtors
Current
1,485,063 GBP2024-12-31
978,726 GBP2023-12-31
Trade Creditors/Trade Payables
Current
67,800 GBP2024-12-31
218,706 GBP2023-12-31
Taxation/Social Security Payable
Current
72,546 GBP2024-12-31
61,411 GBP2023-12-31
Other Creditors
Current
19,594 GBP2024-12-31
17,418 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
324,643 GBP2024-12-31
189,366 GBP2023-12-31
Creditors
Current
484,583 GBP2024-12-31
486,901 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
284,337 GBP2024-12-31
284,337 GBP2023-12-31
Between one and five year
1,057,175 GBP2024-12-31
1,089,477 GBP2023-12-31
More than five year
163,281 GBP2024-12-31
415,316 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
1,504,793 GBP2024-12-31
1,789,130 GBP2023-12-31
Related profiles found in government register
  • ISOMERASE THERAPEUTICS LIMITED
    Info
    Registered number 08335008
    icon of addressFirst Floor Newnham Building, Chesterford Research Park, Little Chesterford, Cambridge CB10 1XL
    Private Limited Company incorporated on 2012-12-18 (12 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-31
    CIF 0
  • ISOMERASE THERAPEUTICS LIMITED
    S
    Registered number 08335008
    icon of addressNewnham Building, Chesterford Park, Little Chesterford, Saffron Walden, England, CB10 1XL
    Private Company Limited By Shares in Uk Register Of Companies, United Kingdom
    CIF 1 CIF 2
  • ISOMERASE THERAPEUTICS LTD
    S
    Registered number 08335008
    icon of addressNewnham Building, Chesterford Park, Little Chesterford, Saffron Walden, England, CB10 1XL
    Limited Company in Companies House, England
    CIF 3
child relation
Offspring entities and appointments
Active 3
  • 1
    icon of addressNewnham Building Chesterford Park, Little Chesterford, Saffron Walden, England
    Dissolved Corporate (3 parents)
    Equity (Company account)
    1 GBP2024-02-29
    Person with significant control
    icon of calendar 2020-02-13 ~ dissolved
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Ownership of shares – 75% or more → OE
  • 2
    icon of addressNewnham Building Chesterford Park, Little Chesterford, Saffron Walden, England
    Dissolved Corporate (3 parents)
    Equity (Company account)
    1 GBP2024-02-29
    Person with significant control
    icon of calendar 2020-02-13 ~ dissolved
    CIF 2 - Right to appoint or remove directors → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Ownership of shares – 75% or more → OE
  • 3
    icon of addressNewnham Building Chesterford Park, Little Chesterford, Saffron Walden, England
    Dissolved Corporate (3 parents)
    Equity (Company account)
    0.01 GBP2024-03-31
    Person with significant control
    icon of calendar 2017-03-14 ~ dissolved
    CIF 3 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.